Johansen, P., Håkan-Bloch, J., Liu, A. R., Bech, P. G., Persson, S., & Leiter, L. A. (2019). Cost Effectiveness of Once-Weekly Semaglutide Versus Once-Weekly Dulaglutide in the Treatment of Type 2 Diabetes in Canada. Pharmacoecon Open.

Johansen, Pierre, Jonas Håkan-Bloch, Aiden R. Liu, Peter G. Bech, Sofie Persson, and Lawrence A. Leiter. "Cost Effectiveness of Once-Weekly Semaglutide Versus Once-Weekly Dulaglutide in the Treatment of Type 2 Diabetes in Canada." Pharmacoecon Open 2019.

Johansen, Pierre, et al. "Cost Effectiveness of Once-Weekly Semaglutide Versus Once-Weekly Dulaglutide in the Treatment of Type 2 Diabetes in Canada." Pharmacoecon Open 2019.